-
HATU for Selective Inhibitor Synthesis
2026-08-20
HATU enables efficient carboxylic acid activation for amide and ester construction, but its greatest value is revealed when synthesis quality is connected to biochemical assay interpretation. This article applies that perspective to structure-guided inhibitor libraries inspired by IRAP and ERAP research.
-
Haloprogin: Evidence from a 1970 Topical Study
2026-08-19
The 1970 study established Haloprogin as a topical antimicrobial with dermatophyte activity comparable to tolnaftate, while also showing activity against Candida species and selected Gram-positive bacteria. Its paired in vitro, formulation, and guinea pig infection experiments provide a useful framework for interpreting spectrum, matrix effects, and topical efficacy.
-
IEM 1460: AMPA Receptor Blocker Guide
2026-08-19
IEM 1460 is a selective AMPA receptor blocker for neuroscience research on excitatory signaling, excitotoxicity, and synaptic transmission. This guide separates product specifications from indirect evidence involving the related compound IEM-1925 in a rat soman model.
-
LY-411575 Workflow for Aβ and Notch Studies
2026-08-18
Build reproducible Alzheimer’s disease and cancer research workflows around LY-411575 by pairing Aβ or NICD measurements with cell-health and functional controls. The guide covers solvent handling, dose design, neuronal validation, Notch assays, and troubleshooting for interpreting pathway inhibition without overclaiming selectivity.
-
NF 340: A Mechanistic Map of P2Y11 Signaling
2026-08-18
NF 340 is a selective P2Y11 antagonist for testing purinergic control of cell migration, myosin light-chain phosphorylation, and cancer invasiveness. This mechanistic guide connects the product’s chemistry and handling requirements with evidence-based assay design and careful causal interpretation.
-
hCG, H3K27me3, and CXCL10 in Decidua
2026-08-17
The reference study shows that human chorionic gonadotropin suppresses CXCL10 in human decidual stromal cells by promoting EZH2-dependent H3K27me3 deposition at the CXCL10 promoter. This chromatin-based mechanism links placental hormone signaling with selective CD8 T-cell recruitment and provides a framework for studying immune regulation at the maternal-fetal interface.
-
JHU-083: A Redox-Aware Glutaminase Strategy
2026-08-17
JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor for selective glutaminase pathway research. This article shows how to combine compartment-specific glutamate measurements with redox and cell-death assays, using recent GSTA1 findings to improve interpretation in neurological models.
-
NHS-Biotin: From Labeling Chemistry to Protein Systems
2026-08-16
NHS-Biotin connects precise amine-reactive chemistry with modern protein engineering, enabling researchers to track, detect, and purify antibodies, nanobodies, and intracellular proteins while preserving a pathway toward translationally useful assay control.
-
Thymosin-β4, Notch/NF-κB, and Limb Ischemia
2026-08-15
The reference study shows that thymosin-β4 promotes endothelial angiogenic activity and neovascularization in a mouse model of critical limb ischemia through coordinated Notch and NF-κB pathway regulation. Its combination of gain-of-function experiments, pathway inhibitors, cellular assays, and tissue-level validation provides a useful framework for evaluating mechanistic links between signaling and therapeutic angiogenesis.
-
LRPPRC–Dasatinib Synergy Disrupts Tumor OXPHOS
2026-08-14
A 2026 study identified dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central innovation is a dual-genome mechanism in which LRPPRC inhibition preferentially disrupts mitochondrial-encoded OXPHOS programs, while dasatinib suppresses nuclear-encoded OXPHOS genes.
-
Danazol Research: Protocols, Models, and Troubleshooting
2026-08-14
Danazol supports controlled studies of steroidogenesis, hypothalamic–pituitary–gonadal axis activity, and androgen receptor signaling. This practical guide connects cell-based assays with a recent rat model of precocious puberty while emphasizing solvent control, exposure design, and phenotype-specific troubleshooting.
-
Pyridostatin TFA: G-Quadruplex Assay Guide
2026-08-13
Pyridostatin TFA gives researchers a practical way to stabilize G-quadruplexes while connecting telomere biology research with cancer and protein-condensation assays. This guide translates product specifications and recent TDP-43 findings into dose planning, controls, workflow choices, and troubleshooting steps.
-
MG-132: Reliable Apoptosis Assay Workflows
2026-08-13
This scenario-driven guide explains how MG-132 (SKU A2585) can improve interpretation of viability, apoptosis, cell-cycle, and oxidative-stress experiments. It connects product-specific handling data with practical controls, dose selection, and recent ROS-related literature for more reproducible laboratory decisions.
-
Super-Enhancers Drive SLC7A11-Linked Disulfidptosis
2026-08-12
The reference study defines a super-enhancer–FOXA1–SLC7A11 regulatory axis that links prostate cancer transcriptional control with disulfidptosis under glucose stress. Its combined genomic, computational, genetic, and functional approach suggests that nutrient-dependent cell death may be exploited through regulatory elements controlling cystine metabolism.
-
Rocket-Like Nanomedicine Restores PDAC Stroma
2026-08-12
Fu et al. developed an acid-responsive, core–shell nanomedicine that first remodels pancreatic tumor stroma and then improves gemcitabine delivery. In a pancreatic ductal adenocarcinoma mouse model, the platform produced marked tumor regression without reported treatment-related side effects, supporting stromal homeostasis restoration as an alternative to nonspecific stromal ablation.